Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle
César Vásquez-Trincado, Julia Dunn, Ji In Han, Briyanna Hymms, Jaclyn Tamaroff, Monika Patel, Sara Nguyen, Anna Dedio, Kristin Wade, Chinazo Enigwe, Zuzana Nichtova, David R. Lynch, Gyorgy Csordas, Shana E. McCormack, Erin L. Seifert
César Vásquez-Trincado, Julia Dunn, Ji In Han, Briyanna Hymms, Jaclyn Tamaroff, Monika Patel, Sara Nguyen, Anna Dedio, Kristin Wade, Chinazo Enigwe, Zuzana Nichtova, David R. Lynch, Gyorgy Csordas, Shana E. McCormack, Erin L. Seifert
View: Text | PDF
Research Article Muscle biology

Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle

  • Text
  • PDF
Abstract

Friedreich’s ataxia (FRDA) is an inherited disorder caused by reduced levels of frataxin (FXN), which is required for iron-sulfur cluster biogenesis. Neurological and cardiac comorbidities are prominent and have been a major focus of study. Skeletal muscle has received less attention despite indications that FXN loss affects it. Here, we show that lean mass is lower, whereas body mass index is unaltered, in separate cohorts of adults and children with FRDA. In adults, lower lean mass correlated with disease severity. To further investigate FXN loss in skeletal muscle, we used a transgenic mouse model of whole-body inducible and progressive FXN depletion. There was little impact of FXN loss when FXN was approximately 20% of control levels. When residual FXN was approximately 5% of control levels, muscle mass was lower along with absolute grip strength. When we examined mechanisms that can affect muscle mass, only global protein translation was lower, accompanied by integrated stress response (ISR) activation. Also in mice, aerobic exercise training, initiated prior to the muscle mass difference, improved running capacity, yet, muscle mass and the ISR remained as in untrained mice. Thus, FXN loss can lead to lower lean mass, with ISR activation, both of which are insensitive to exercise training.

Authors

César Vásquez-Trincado, Julia Dunn, Ji In Han, Briyanna Hymms, Jaclyn Tamaroff, Monika Patel, Sara Nguyen, Anna Dedio, Kristin Wade, Chinazo Enigwe, Zuzana Nichtova, David R. Lynch, Gyorgy Csordas, Shana E. McCormack, Erin L. Seifert

×

Figure 7

Exercise training enhances running tolerance in FXN-depleted mice but has little effect on the ISR in muscle.

Options: View larger image (or click on image) Download as PowerPoint
Exercise training enhances running tolerance in FXN-depleted mice but ha...
All measurements were done in WT and TG mice fed with Doxy for 18 weeks, using quadriceps lysates. (A) Treadmill protocol for sedentary (Sed) and trained (Tr) mice. An acclimation period (Acclim) was allowed for both experimental groups. A running test (Test) was performed at the end of the acclimation for Sed mice and at the end of 4 weeks of training for Tr mice. Treadmill incline (°) and speed (m/min) are shown. Speed transitions (e.g., 5–10 and 10–15 m/min) describe initial and final speeds each week or a speed progression on a given day. (B) Running time for the Test run (n = 5 Sed/8 Tr per genotype). (C) Blood lactate levels before and after the Test run (n = 5 Sed/8 Tr per genotype). (D) BW, TW, FL, TW/BW, and TW/FL, n = 5 Sed/8 Tr per genotype. (E) Transcript levels (normalized to Actb, relative to WT) of Mthfd2, Gdf15, and Fgf21 (n = 5 Sed/8 Tr per genotype). (F) Left: Representative immunoblots of p-eIF2α (Ser51), total eIF2α, MTHFD2, ASNS, and GRB2 (loading control). Right: Quantification, n = 5 Sed/8 Tr per genotype. (G) Quantification of abnormal mitochondria (%), by analysis of electron micrographs from quadriceps. Number of fields analyzed: 13–25 fields/sample, n = 5 Sed/3 Tr. (H) Left: Representative immunoblots of LC3 (GRB2: loading control). Right: Quantification. Sed and Tr WT and TG mice were treated with colchicine (n = 3/group). Quadriceps lysates from Sed mice were also used in Figure 4D. All panels: individual data points are shown, and bars represent mean ± SEM. (B–E and H) Two-way ANOVA, post hoc comparisons: Bonferroni’s correction (P values shown). (F and G) Unpaired t test, *P = 0.05, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts